Rief W - Search Results

1

Implications of Placebo and Nocebo Effects for Clinical Practice: Expert Consensus.

Evers AWM, Colloca L, Blease C, Annoni M, Atlas LY, Benedetti F, Bingel U, Büchel C, Carvalho C, Colagiuri B, Crum AJ, Enck P, Gaab J, Geers AL, Howick J, Jensen KB, Kirsch I, Meissner K, Napadow V, Peerdeman KJ, Raz A, Rief W, Vase L, Wager TD, Wampold BE, Weimer K, Wiech K, Kaptchuk TJ, Klinger R, Kelley JM. Evers AWM, et al. Among authors: rief w. Psychother Psychosom. 2018;87(4):204-210. doi: 10.1159/000490354. Epub 2018 Jun 12. Psychother Psychosom. 2018. PMID: 29895014 Free PMC article.

2

Recent trends in behavioral medicine.

Nater UM, Gaab J, Rief W, Ehlert U. Nater UM, et al. Among authors: rief w. Curr Opin Psychiatry. 2006 Mar;19(2):180-3. doi: 10.1097/01.yco.0000214345.37002.77. Curr Opin Psychiatry. 2006. PMID: 16612200 Review.

3

Mechanisms involved in placebo and nocebo responses and implications for drug trials.

Rief W, Bingel U, Schedlowski M, Enck P. Rief W, et al. Clin Pharmacol Ther. 2011 Nov;90(5):722-6. doi: 10.1038/clpt.2011.204. Epub 2011 Oct 5. Clin Pharmacol Ther. 2011. PMID: 21975346 No abstract available.

4

The placebo response in medicine: minimize, maximize or personalize?

Enck P, Bingel U, Schedlowski M, Rief W. Enck P, et al. Among authors: rief w. Nat Rev Drug Discov. 2013 Mar;12(3):191-204. doi: 10.1038/nrd3923. Nat Rev Drug Discov. 2013. PMID: 23449306 Review.

5

Avoiding nocebo effects to optimize treatment outcome.

Bingel U; Placebo Competence Team. Bingel U, et al. JAMA. 2014 Aug 20;312(7):693-4. doi: 10.1001/jama.2014.8342. JAMA. 2014. PMID: 25003609 Free article. No abstract available.

6

Catechol-O-methyltransferase Val158Met polymorphism is associated with somatosensory amplification and nocebo responses.

Wendt L, Albring A, Benson S, Engler H, Engler A, Hinney A, Rief W, Witzke O, Schedlowski M. Wendt L, et al. Among authors: rief w. PLoS One. 2014 Sep 15;9(9):e107665. doi: 10.1371/journal.pone.0107665. eCollection 2014. PLoS One. 2014. PMID: 25222607 Free PMC article.

7

Neuro-Bio-Behavioral Mechanisms of Placebo and Nocebo Responses: Implications for Clinical Trials and Clinical Practice.

Schedlowski M, Enck P, Rief W, Bingel U. Schedlowski M, et al. Among authors: rief w. Pharmacol Rev. 2015 Jul;67(3):697-730. doi: 10.1124/pr.114.009423. Pharmacol Rev. 2015. PMID: 26126649 Review.

8

Rethinking psychopharmacotherapy: The role of treatment context and brain plasticity in antidepressant and antipsychotic interventions.

Rief W, Barsky AJ, Bingel U, Doering BK, Schwarting R, Wöhr M, Schweiger U. Rief W, et al. Neurosci Biobehav Rev. 2016 Jan;60:51-64. doi: 10.1016/j.neubiorev.2015.11.008. Epub 2015 Nov 23. Neurosci Biobehav Rev. 2016. PMID: 26616735 Free article. Review.

9

Assessment of adverse events in clinical drug trials: Identifying amitriptyline's placebo- and baseline-controlled side effects.

Rheker J, Rief W, Doering BK, Winkler A. Rheker J, et al. Among authors: rief w. Exp Clin Psychopharmacol. 2018 Jun;26(3):320-326. doi: 10.1037/pha0000194. Exp Clin Psychopharmacol. 2018. PMID: 29863388 Clinical Trial.

10

Psychobiological Mechanisms of Placebo and Nocebo Effects: Pathways to Improve Treatments and Reduce Side Effects.

Petrie KJ, Rief W. Petrie KJ, et al. Among authors: rief w. Annu Rev Psychol. 2019 Jan 4;70:599-625. doi: 10.1146/annurev-psych-010418-102907. Epub 2018 Aug 15. Annu Rev Psychol. 2019. PMID: 30110575 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

542 results

Search Page